| 
		U.S. warns doctors to look for hepatitis in children as probe widens
		 Send a link to a friend 
		
		 [April 22, 2022] 
		By Julie Steenhuysen 
 CHICAGO (Reuters) - U.S. health officials 
		have sent out a nationwide alert warning doctors to be on the lookout 
		for symptoms of pediatric hepatitis, possibly linked with a cold virus, 
		as part of a wider probe into unexplained cases of severe liver 
		inflammation in young children.
 
 The warning follows investigations in the United States and Europe of 
		clusters of hepatitis in young children.
 
 The U.S. Centers for Disease Control and Prevention (CDC) said it is 
		working with counterparts in Europe to understand the cause of the 
		infections. A common cold virus known as an adenovirus has been 
		confirmed in several of the European cases, but not all.
 
 UK health authorities on Thursday said they have identified a total of 
		108 cases of pediatric hepatitis. In some instances, cases were so 
		severe that children required liver transplants.
 
 Additional cases have been reported in Denmark, Ireland, the Netherlands 
		and Spain, according to the European Centre for Disease Prevention and 
		Control.
 
		
		 
		The U.S. alert directs doctors to report any suspected cases of the 
		disease that occur with unknown origin to their state and local health 
		departments.
 It also suggests doctors conduct adenovirus testing in young patients 
		with symptoms of the disease, which include fever, fatigue, loss of 
		appetite, nausea, vomiting, abdominal pain, dark urine, light-colored 
		stools, joint pain, and jaundice.
 
 The warning followed a CDC investigation with the Alabama Department of 
		Public Health into a cluster of nine cases of hepatitis of unknown 
		origin in previously healthy children ranging in age from 1 to 6-years 
		old.
 
 The first such U.S. cases were identified in October 2021 at a 
		children’s hospital in Alabama that admitted five young patients with 
		significant liver injury - including some with acute liver failure - of 
		unknown cause. In those cases, the children tested positive for 
		adenovirus.
 
 The more common forms of the liver disease - hepatitis A, hepatitis B, 
		and hepatitis C - were ruled out.
 
 
		[to top of second column] | 
            
			 
            
			People walk into the Children's Hospital of Georgia in Augusta, 
			Georgia, U.S., January 14, 2022. REUTERS/Hannah Beier 
            
			 A review of hospital records identified four 
			additional cases, all of whom had liver injury and adenovirus 
			infection. Lab tests found that some of these children were infected 
			with adenovirus type 41, which causes acute infection of the 
			digestive system. The state has not found any new cases beyond the 
			original cluster.
 The CDC is working with state health departments to identify U.S. 
			cases. While the leading theory is that the cases are caused by a 
			specific type of adenovirus, health officials are considering other 
			possible contributing factors as well.
 
 Scotland’s public health agency first raised the alarm about unusual 
			hepatitis cases in children on April 6. There have now been 14 cases 
			identified in the country, including one additional case under 
			investigation this week, Public Health Scotland director Jim 
			McMenamin told Reuters.
 
 Increasingly researchers believe that adenovirus infection could be 
			behind the cases, possibly “in concert” with another virus, as 77% 
			of the children in the UK had tested positive for adenovirus, 
			McMenamin said.
 
 However, he said, other causes have not been ruled out, including 
			toxin exposure, COVID-19, or a novel pathogen, either in tandem with 
			adenovirus infection, or alone.
 
 None of the UK or U.S. cases have been linked with the COVID-19 
			vaccine. And Alabama state health officials said none of the nine 
			cases there had any history of prior COVID-19 infection.
 
 (Reporting by Julie Steenhuysen; additional reporting by Jennifer 
			Rigby in London; Editing by Bill Berkrot)
 
			[© 2022 Thomson Reuters. All rights 
				reserved.]  This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content. 
			
			 |